SEC Company Response from HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT, HSDTW) (CIK 0001610853) (HSDT) — Feb 4, 2020
HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT, HSDTW) (CIK 0001610853)
Date: Feb. 4, 2020 · CIK: 0001610853 · Accession: 0001193125-20-024306
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236101
Letter
Helius Medical Technologies, Inc.
642 Newtown Yardley Road, Suite 100
Newtown, PA 18940
February 4, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Chris Edwards
RE:
Helius Medical Technologies, Inc.
Registration Statement on Form S-3
File No. 333-236101
Acceleration Request
Requested Date:
February 6, 2020
Requested Time:
4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) to become effective on February 6, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Owen Williams, counsel to the Registrant, at (202) 842-7843.
Very truly yours,
Helius Medical Technologies, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Helius Medical Technologies, Inc. 642 Newtown Yardley Road, Suite 100 Newtown, PA 18940 February 4, 2020 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Chris Edwards RE: Helius Medical Technologies, Inc. Registration Statement on Form S-3 File No. 333-236101 Acceleration Request Requested Date: February 6, 2020 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) to become effective on February 6, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Owen Williams, counsel to the Registrant, at (202) 842-7843. Very truly yours, Helius Medical Technologies, Inc. /s/ Joyce LaViscount Joyce LaViscount Chief Financial Officer and Chief Operating Officer cc: Philippe Deschamps, President and Chief Executive Officer Darren K. DeStefano, Cooley LLP Jeffrey Libson, Cooley LLP